Literature DB >> 7536510

Expression of c-kit receptor (CD117) and CD34 in leukemic cells.

K Muroi1, M Nakamura, Y Amemiya, T Suda, Y Miura.   

Abstract

The expression of c-kit receptor (c-kit R; CD117) and CD34 was examined in acute myeloid leukemia (AML), acute lymphoid leukemia (ALL), chronic myeloid leukemia (CML) in blastic transformation (BT), and myelofibrosis (MF) in myeloid BT. In myeloid leukemia including AML, CML-myeloid BT and MF-myeloid BT, both c-kit R and CD34 were expressed synchronously, while in lymphoid leukemia including ALL and CML-lymphoid BT, only CD34 was highly expressed. A close correlation between c-kit R and CD33 expression and an inverse correlation between c-kit R and CD19 expression were observed when all of the myeloid plus lymphoid leukemia cells were analysed. There was a close correlation between c-kit R and CD34 expression in the myeloid leukemia cells. c-kit R expression may be associated with myeloid phenotypes of leukemic cells and may be useful for the diagnosis of myeloid leukemia. The literature of c-kit R expression in leukemic cells is reviewed here and the comparison of c-kit R and CD34 expression in normal hematopoietic progenitor cells with those on the leukemic counterparts was discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7536510     DOI: 10.3109/10428199509049769

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  3 in total

1.  TDT (-), KIT (+), CD34 (+), CD99 (+) precursor T lymphoblastic leukemia/lymphoma.

Authors:  Tadashi Terada
Journal:  Int J Clin Exp Pathol       Date:  2012-02-12

2.  Diagnostic value of CD117 in differential diagnosis of acute leukemias.

Authors:  Abbas Ahmadi; Ali-Akbar Poorfathollah; Mahnaz Aghaiipour; Mansour Rezaei; Mahin Nikoo-ghoftar; Mohammad Abdi; Alireza Gharib; Amir Amini
Journal:  Tumour Biol       Date:  2014-04-11

3.  Critical Requirement of SOS1 for Development of BCR/ABL-Driven Chronic Myelogenous Leukemia.

Authors:  Carmela Gómez; Rósula Garcia-Navas; Fernando C Baltanás; Rocío Fuentes-Mateos; Alberto Fernández-Medarde; Nuria Calzada; Eugenio Santos
Journal:  Cancers (Basel)       Date:  2022-08-11       Impact factor: 6.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.